Xuelin Huang

The University of Texas MD Anderson Cancer Center

Also affiliated with Energy Storage Systems (United States), Guangdong Province Women and Children Hospital

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study”.

Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa358

N/A

3.1DataRank · unranked

77 citations

David McCue, Sebastian Wurster, Nathan P. Wiederhold, Marina Konopleva, Tapan M. Kadia +18 more

Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML

Journal of Clinical Oncology(2024)10.1200/jco.23.01911

N/A

2.7DataRank · unranked

152 citations

Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Lewis Nasr, Walid Macaron +19 more

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01476-8

N/A

1.3DataRank · unranked

51 citations

Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo +22 more

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

Blood Cancer Journal(2023)10.1038/s41408-023-00830-w

N/A

0.968DataRank · unranked

31 citations

Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B. Ostermann, Xuelin Huang +11 more

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia

Blood Advances(2024)10.1182/bloodadvances.2023012231

N/A

0.940DataRank · unranked

34 citations

Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Nasr, Fadi Haddad +18 more

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies

JAMA(2024)10.1001/jama.2023.24766

N/A

0.598DataRank · unranked

53 citations

Christina Chapman, Jinani Jayasekera, Kathryn P. Lowry, Brandy M. Heckman‐Stoddard, John M. Hampton +30 more

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML

Blood Neoplasia(2025)10.1016/j.bneo.2025.100071

N/A

0.166DataRank · unranked

2 citations

Woonbok Chung, Raji Shameem, Lianchun Xiao, Curt Balch, Xuelin Huang +2 more

CondiS web app: imputation of censored lifetimes for machine learning-based survival analysis

Bioinformatics(2022)10.1093/bioinformatics/btac461

N/A

0DataRank · unranked

1 citations

Christopher R. Flowers, Ziyi Li, Xuelin Huang, Yizhuo Wang

Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity

Blood Advances(2023)10.1182/bloodadvances.2022009391

N/A

0DataRank · unranked

29 citations

Tapan M. Kadia, Nicholas J. Short, Gautam Borthakur, Sa A. Wang, Wei Wang +22 more

MASH: Mediation Analysis of Survival Outcome and High-dimensional Omics Mediators with Application to Complex Diseases

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.22.554286

N/A

0DataRank · unranked

4 citations

Christopher R. Flowers, Ziyi Li, Xuelin Huang, Peng Wei, Sunyi Chi

Bayesian Learning of Personalized Longitudinal Biomarker Trajectory

Annals of Data Science(2023)10.1007/s40745-023-00486-0

N/A

0DataRank · unranked

0 citations

Xuelin Huang, Chan Shen, Hagop M. Kantarjian, Shouhao Zhou

Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0471

N/A

0DataRank · unranked

21 citations

Michael W. Lloyd, Soner Koc, Yvonne A. Evrard, Lisa M. McShane, Michael T. Lewis +29 more

MASH: Mediation analysis of survival outcome and high-dimensional omics mediators with application to complex diseases

The Annals of Applied Statistics(2024)10.1214/23-aoas1838

N/A

0DataRank · unranked

6 citations

Christopher R. Flowers, Ziyi Li, Xuelin Huang, Peng Wei, Sunyi Chi

A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening

The Prostate(2024)10.1002/pros.24686

N/A

0DataRank · unranked

6 citations

Lisly Chéry, Graciela M. Nogueras‐González, Chad D. Huff, Sara S. Strom, Jeffrey A. Jones +13 more

CASi: A framework for cross-timepoint analysis of single-cell RNA sequencing data

Scientific Reports(2024)10.1038/s41598-024-58566-x

N/A

0DataRank · unranked

1 citations

Christopher R. Flowers, Michael Wang, Xuelin Huang, Ziyi Li, Yizhuo Wang

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016565

N/A

0DataRank · unranked

3 citations

Hagop M. Kantarjian, Nitin B. Jain, Tapan M. Kadia, Jayastu Senapati, Fadi Haddad +12 more

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network

Journal of Breast Imaging(2025)10.1093/jbi/wbaf003

N/A

0DataRank · unranked

3 citations

Jennifer L. Caswell‐Jin, Harry J. de Koning, Hui Huang, Xuelin Huang, Sandra J. Lee +10 more

Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia

Blood Cancer Journal(2025)10.1038/s41408-025-01266-0

N/A

0DataRank · unranked

3 citations

Yuki Nishida, Kyung Hee Chang, Andrea Bedoy, Muharrem Müftüoğlu, Wencai Ma +13 more

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine

Statistics in Medicine(2025)10.1002/sim.70103

N/A

0DataRank · unranked

2 citations

Dejian Lai, Ruosha Li, Han Chen, Xuelin Huang, Jing Ning +1 more

A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over time

Statistical Methods in Medical Research(2025)10.1177/09622802251320793

N/A

0DataRank · unranked

0 citations

Xuelin Huang, Ruosha Li, Yu Shen, Nicholas J. Short, Kapil N. Bhalla +1 more

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

JAMA Oncology(2020)10.1001/jamaoncol.2020.4600

N/A

0DataRank · unranked

373 citations

Shouhao Zhou, Chenqi Fu, Donald A. Berry, Roland B. Walter, Sylvie Freeman +8 more

MELODY: Mediation Analysis in Logistic Regression for High-Dimensional Mediators and a Binary Outcome

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.12.688038

N/A

0DataRank · unranked

0 citations

Xingyu Li, Peng Wei, Xuelin Huang, Sunyi Chi

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Leukemia(2020)10.1038/s41375-020-0778-0

N/A

0DataRank · unranked

52 citations

Srđan Verstovšek, Jörge E. Cortes, Susan Tse, Yvonne Gasior, Nitin Jain +19 more

Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers

Biometrical Journal(2020)10.1002/bimj.201900112

N/A

0DataRank · unranked

17 citations

Xuelin Huang, Liang Li, Yayuan Zhu

Statistical analysis of clustered mixed recurrent-event data with application to a cancer survivor study

Lifetime Data Analysis(2020)10.1007/s10985-020-09500-6

N/A

0DataRank · unranked

7 citations

Sangbum Choi, Yimei Li, Xuelin Huang, Jianguo Sun, Leslie L. Robison +1 more

Semiparametric modelling and estimation of covariate‐adjusted dependence between bivariate recurrent events

Biometrics(2020)10.1111/biom.13229

N/A

0DataRank · unranked

4 citations

Chunyan Cai, Yong Chen, Xuelin Huang, Mei‐Cheng Wang, Jing Ning

Application of machine learning methods in clinical trials for precision medicine

JAMIA Open(2022)10.1093/jamiaopen/ooab107

N/A

0DataRank · unranked

35 citations

Bing Z. Carter, Ziyi Li, Xuelin Huang, Yizhuo Wang

A flexible‐hazards cure model with application to patients with soft tissue sarcoma

Statistics in Medicine(2022)10.1002/sim.9588

N/A

0DataRank · unranked

2 citations

Xuelin Huang, Ruosha Li, Peter W. T. Pisters, Can Xie